1-2 of 2
Jill Harrison
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The activin receptor-like kinase-2 inhibitor zilurgisertib (INCB000928) as monotherapy or with ruxolitinib in patients with anemia due to myelofibrosis: Phase 1/2 study final results

Free
Prithviraj Bose, Stephen Oh, Anthony Hunter, Francesca Palandri, Haris Ali, Paola Guglielmelli, Vikas Gupta, Tomoki Ito, Jean-Jacques Kiladjian, Taizo Shimomura, Andrew Sochacki, Masahiro Takeuchi, Francoise Boyer, Jason Gotlib, Ellen Ritchie, Michael Savona, Yi Cui, Jill Harrison, Betty Lamothe, Amanda McBride, Sanjay Mohan
Journal: Blood
Blood (2025) 146 (Supplement 1): 3795.
https://doi.org/10.1182/blood-2025-3795
Published: 2025
Journal Articles

Preliminary Results from a Phase I Dose Escalation Trial of Ruxolitinib and the PI3Kδ Inhibitor TGR-1202 in Myelofibrosis

Free
Tamara K Moyo, MD PhD, Andrew Sochacki, MD, Gregory D Ayers, MS, Michael T. Byrne, DO, Stephen A. Strickland, Sanjay R. Mohan, MD, Jill Harrison, Lynne D Berry, Channing V Dudley, Rachel Severs, Laura Dugger, Hari P. Miskin, MS, Amy Cavers, Peter Sportelli, Laura C Michaelis, MD, Ruben A. Mesa, MD, Michael R. Savona, MD
Journal: Blood
Blood (2016) 128 (22): 1125.
https://doi.org/10.1182/blood.V128.22.1125.1125
Published: 2016